Cosmo announces United Arab Emirates regulatory approval of GI GENIUS™
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that GI Genius™ has received regulatory approval in the United Arab Emirates. More countries in the Middle East Region are expected to follow in the next months.